Trial intelligence / Profile preview

Phase III trial of astragaloside IV glucose injection for stable angina in coronary artery disease

ChiCTR-TRC-12001974Phase 3Completed

Sponsor
Hospital of Chengdu University of Traditional Chinese Medicine
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of astragaloside iv in coronary arteriosclerosis and stable angina (2 arms), sponsored by Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoints: Number of angina attacks, Angina duration and 2 more. Started Aug 2006; status: completed.

02

Drugs

astragaloside iv
03

Conditions

coronary arteriosclerosisstable angina

Beyond the preview

Go deeper on ChiCTR-TRC-12001974.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12001974.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call